Shah, Shiv
Bhattacharjee, Maumita
Kan, Ho-Man
Marchini, Rachel L.
Schmidt, Tannin A.
Nair, Lakshmi S.
Laurencin, Cato T. http://orcid.org/0000-0001-6765-3047
Funding for this research was provided by:
National Institutes of Health (DP1AR068147, T32AR079114)
Article History
Received: 16 February 2023
Revised: 17 May 2023
Accepted: 20 May 2023
First Online: 15 June 2023
Declarations
:
: University of Connecticut has filed a patent application on behalf of the inventors (S.S., H.M.K., L.S.N., C.T.L) entitled The Synthetic Artificial Stem Cell. L.S.N has the following competing financial interest: Soft tissue regeneration/Biorez. C.T.L. has the following competing financial interests: Mimedx, Alkermes Company, Biobind, Soft tissue regeneration/Biorez, Healing Orthopedic Technologies-Bone.